Investigation of the Structural Requirement for Blocking the Human CCR5 Chemokine Receptor. An Insight from Quantitative Structure Activity Relationships Study

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|6|2|114-124

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.6, Iss.2, 2009-03, pp. : 114-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Antagonists of the Chemokine Receptor CCR5

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-09 ,pp. : 1299-1338

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Activity Relationship Studies: M2 and CCR5 Receptor Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-06 ,pp. : 1155-1169

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1504-1514

Bentham Science Publishers

Access to resources Recommend Favorite

CCR1 Chemokine Receptor Antagonist

By  

Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. : 1201-1208

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Structure-Activity Relationships of Neuromuscular Blocking Agents

By  

Current Medicinal Chemistry, Vol. 9, Iss. 16, 2002-08 ,pp. : 1507-1536

Bentham Science Publishers

Access to resources Recommend Favorite